Company Announcements

Publication of Suppl.Prospcts

Source: RNS
RNS Number : 5847E
Wells Fargo & Company
06 November 2020

Publication of Supplementary Prospectus


The following prospectus has been approved by the UK Listing Authority and is available for viewing:


Supplementary Prospectus dated 6 November 2020 to the Base Prospectus dated 25 March 2020 for the Wells Fargo & Company U.S.$50,000,000,000 Euro Medium Term Note Programme.



To view the full document, please paste the following URL into the address bar of your browser:



A copy of this prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at



For further information, please contact


John Muller








Please note that the information contained in the Supplementary Prospectus or Base Prospectus (collectively, the "Prospectus") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.


Your right to access this service is conditional upon complying with the above requirement. 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.